XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
XTL Biopharmaceuticals Ltd. is set to acquire 100% of the issued and outstanding share capital of THE SOCIAL PROXY LTD., making it a wholly-owned subsidiary. The deal involves a cash payment and equity consideration to the current shareholders of THE SOCIAL PROXY LTD. in exchange for 10,813 ordinary shares. This strategic move is approved by both companies’ boards as being in the best interest of their respective shareholders.
For further insights into XTLB stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money